PET Changes Similar for Alzheimer Disease, Down Syndrome
TUESDAY, Dec. 20, 2022 (HealthDay News) — Positron emission tomography (PET) changes are similar for people with autosomal dominant Alzheimer disease and those with Down syndrome, according to a study published in the January issue of The Lancet Neur…
Learn MoreFirst-Line Regimens With Endocrine Therapy Show Benefits in Breast Cancer
TUESDAY, Dec. 20, 2022 (HealthDay News) — First-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-positive]) metastatic breas…
Learn MoreCommercial Rates for Breast Reconstruction Vary Significantly
TUESDAY, Dec. 20, 2022 (HealthDay News) — There is large nationwide variation in commercial rates for breast reconstruction, according to a study published online Dec. 14 in JAMA Surgery.Danielle H. Rochlin, M.D., from Stanford University Medical Cen…
Learn MoreCombustible Tobacco Use Tied to Adverse Oral Health Outcomes
TUESDAY, Dec. 20, 2022 (HealthDay News) — Tobacco product use is associated with the incidence of several adverse oral health outcomes, according to a study published online Dec. 9 in JAMA Network Open.Marushka L. Silveira, Ph.D., from the U.S. Natio…
Learn MoreOne in Seven Dual Users Continue Using Both Tobacco Products
MONDAY, Dec. 19, 2022 (HealthDay News) — One in seven dual users of electronic nicotine delivery systems (ENDS) and cigarettes continues using both products during six years of follow-up, according to a study published online Dec. 13 in Tobacco Contr…
Learn MoreFDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer
MONDAY, Dec. 19, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin (nadofaragene firadenovec-vncg), which is designed to work for patients with high-risk non-muscle-invasive bladder can…
Learn MoreJane Fonda anuncia que su linfoma está en remisión
VIERNES, 16 de diciembre de 2022 (HealthDay News) — La actriz y ganadora de dos premios Oscar Jane Fonda anunció el jueves que su linfoma no Hodgkin está en remisión.Fonda, que tiene 84 años, afirmó en una publicación en su blog que puede dejar los t…
Learn MoreLa terapia de luz podría aliviar la fatiga relacionada con la EM
VIERNES, 15 de diciembre de 2022 (HealthDay News) — La fatiga extrema con frecuencia encabeza la lista de los síntomas más angustiantes para los millones de personas que viven con la esclerosis múltiple (EM).Y ahora, un nuevo estudio sugiere que la t…
Learn MoreSan Antonio Breast Cancer Symposium, Dec. 6-10
The annual San Antonio Breast Cancer Symposium was held from Dec. 6 to 10 in San Antonio and attracted approximately 8,000 participants from around the world, including medical oncologists, radiation oncologists, researchers, and other health care pr…
Learn MoreHPV Vaccine Refusal Explored Among Cancer Survivors
MONDAY, Dec. 19, 2022 (HealthDay News) — Cancer survivors refusing participation in a trial assessing the safety and immunogenicity of the human papillomavirus (HPV) vaccine do so mainly due to vaccine-related concerns, according to a study published…
Learn More